351. Prognostic factors for achieving resection following neoadjuvant radiation therapy for borderline resectable pancreatic adenocarcinoma
- Author
-
Timothy M. Pawlik, Rachit Kumar, Laura D. Wood, Daniel A. Laheru, Ana De Jesus-Acosta, Katherine Y. Fan, Susannah G. Ellsworth, Zeshaan A. Rasheed, Aaron T. Wild, Siva P. Raman, E K Fishman, Christopher L. Wolfgang, Ralph H. Hruban, Amy Hacker-Prietz, John L. Cameron, D.T. Le, Lei Zheng, Martin A. Makary, Joseph M. Herman, and Avani S. Dholakia
- Subjects
Cancer Research ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,medicine.disease ,Resection ,Surgery ,Radiation therapy ,Oncology ,Borderline resectable ,Pancreatic cancer ,Ascites ,Overall survival ,Medicine ,Adenocarcinoma ,medicine.symptom ,business ,Neoadjuvant chemoradiotherapy - Abstract
285 Background: Margin-negative (R0) surgical resection is the only potentially curative therapy for pancreatic cancer. For patients deemed borderline resectable (BL), neoadjuvant chemoradiotherapy (NCRT) increases the likelihood of subsequent R0 resection and improves overall survival. Prognostic factors for achieving resection following NCRT have yet to be clearly identified. Methods: 50 consecutive patients diagnosed with BL pancreatic cancer by a multidisciplinary tumor board from 2008-12 were retrospectively identified. Pre- and post-NCRT CT scans and surgical specimens were centrally reviewed by a blinded radiologist and pathologist, respectively. Results: 29 patients underwent resection following NCRT, while 21 remained unresectable. Between the two groups, age, gender, mean RT dose, and proportion of pancreatic head tumors were not significantly different. Lack of the following factors was favorably associated with resection: SMV/PV encasement (p=0.01), SMA involvement (p=0.02), ascites (p=0.01), and questionable/overt metastases (p=0.01). Notably, celiac artery involvement/encasement, common hepatic artery encasement, and percentage change in tumor volume were not significant predictors of resectability (all p>0.05). Additionally, tumor volume and degree of individual vessel involvement did not significantly change from scans before and after NCRT (all p>0.05). Median OS was 22.9 vs.13.0 months in resected and unresected patients, respectively (p
- Published
- 2013